Reports

Ideas That Generate Results

Global CRISPR/Cas9 Market Outlook 2022

Global CRISPR/Cas9 Market Outlook 2022

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Oct, 2016| No. of Pages : 80

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00
CD-ROM Mail Delivery
US$ 1300.00
Hard Copy Mail Delivery
US$ 1300.00
Electronic Access - Multi-User License
US$ 2000.00
1. Analyst View

2. Research Methodology

3. Introduction to CRISPR/Cas9 Genome Editing

4. Market Dynamics
     4.1 Market Drivers
            4.1.1 Expanding Drug Discovery Market
            4.1.2 Surging Demand for Synthetic Genes
            4.1.3 Rising Prevalence of Genetic Disorders
            4.1.4 Increasing Investments
     4.2 Market Challenges
            4.2.1 Ethical Issues Concerning Misuse of CRISPR Gene Editing Tool
            4.2.2 Presence of Alternative Gene Editing Tools
     4.3 Market Opportunities
            4.3.1 Increasing Usage of CRISPR Gene Editing for Gene Surgery
            4.3.2 Enhancing Plant Immunity with CRISPR/Cas9
            4.3.3 Emerging Contract Research Market for CRISPR/Cas9

5. Global CRISPR/Cas9 Market Outlook to 2022

6. CRISPR/Cas9 Market by Application
     6.1 Cell Line Engineering
     6.2 Genetic Engineering
     6.3 CRISPR Plasmid
     6.4 Gene Library
     6.5 Human Stem Cells
     6.6 Genetically Modified (GM) Organisms/Crops

7. CRISPR/Cas9 Market by End User
     7.1 Academic & Research Institutes
     7.2 Pharma/Biotech Companies
     7.3 Others

8. CRISPR/Cas9 Market by Geography
     8.1 North America
     8.2 Europe
     8.3 Asia Pacific
     8.4 Rest of the World (RoW)

9. Mergers and Collaborations

10. Company Profiles
       10.1 GE Healthcare
       10.2 Thermo Fisher Scientific, Inc.
       10.3 Agilent Technologies, Inc.
       10.4 Lonza
       10.5 GenScript
       10.6 Horizon Discovery Group plc.
       10.7 Editas Medicine, Inc.
       10.8 CRISPR Therapeutics
       10.9 Caribou Biosciences, Inc.
       10.10 Intellia Therapeutics, Inc.
       10.11 Integrated DNA Technologies
       10.12 OriGene Technologies, Inc.
       10.13 Transposagen Biopharmaceuticals, Inc.
       10.14 New England Biolabs Inc.
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.